Your browser doesn't support javascript.
loading
Temporal Trends, Characteristics, and Outcomes of Infective Endocarditis After Transcatheter Aortic Valve Replacement.
Del Val, David; Abdel-Wahab, Mohamed; Linke, Axel; Durand, Eric; Ihlemann, Nikolaj; Urena, Marina; Pellegrini, Costanza; Giannini, Francesco; Landt, Martin; Auffret, Vincent; Sinning, Jan Malte; Cheema, Asim; Nombela-Franco, Luis; Chamandi, Chekrallah; Campelo-Parada, Francisco; Munoz-Garcia, Antonio; Herrmann, Howard C; Testa, Luca; Won-Keun, Kim; Castillo, Juan Carlos; Alperi, Alberto; Tchetche, Didier; Bartorelli, Antonio; Kapadia, Samir; Stortecky, Stefan; Amat-Santos, Ignacio; Wijeysundera, Harindra C; Lisko, John; Gutiérrez-Ibanes, Enrique; Serra, Vicenç; Salido, Luisa; Alkhodair, Abdullah; Livi, Ugolino; Chakravarty, Tarun; Lerakis, Stamatios; Vilalta, Victoria; Regueiro, Ander; Romaguera, Rafael; Barbanti, Marco; Masson, Jean-Bernard; Maes, Frédéric; Fiorina, Claudia; Miceli, Antonio; Kodali, Susheel; Ribeiro, Henrique B; Mangione, Jose Armando; de Brito, Fabio Sandoli; Actis Dato, Guglielmo Mario; Rosato, Francesco; Ferreira, Maria-Cristina.
Afiliação
  • Del Val D; Quebec Heart and Lung Institute, Laval University, Quebec City, Canada.
  • Abdel-Wahab M; Heart Center Leipzig at University of Leipzig, Leipzig, Germany.
  • Linke A; Heart Center, Segeberger Kliniken, Bad Segeberg, Germany.
  • Durand E; Heart Center Leipzig at University of Leipzig, Leipzig, Germany.
  • Ihlemann N; Herzzentrum Dresden, Technische Universität Dresden, Dresden, Germany.
  • Urena M; Hôpital Charles Nicolle, University of Rouen, Rouen, France.
  • Pellegrini C; Righospitalet, Copenhagen, Denmark.
  • Giannini F; Bichat Hôpital, Paris, France.
  • Landt M; Deutsches Herzzentrum München, Munich, Germany.
  • Auffret V; Ospedale San Raffaele, Milan, Italy.
  • Sinning JM; Maria Cecilia Hospital, GVM Care and Research, Cotignola RA, Italy.
  • Cheema A; Heart Center, Segeberger Kliniken, Bad Segeberg, Germany.
  • Nombela-Franco L; Centre Hospitalier Universitaire de Rennes, Rennes, France.
  • Chamandi C; Heart Center Bonn, Bonn, Germany.
  • Campelo-Parada F; St Michaels Hospital, Toronto, Canada.
  • Munoz-Garcia A; Southlake Regional Health Centre, Newmarket, Canada.
  • Herrmann HC; Cardiovascular Institute, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
  • Testa L; Hôpital Européen Georges Pompidou, Paris, France.
  • Won-Keun K; Hôpital Rangueil, Toulouse, France.
  • Castillo JC; Hospital Universitario Virgen de la Victoria, Malaga, Spain.
  • Alperi A; Hospital of the University of Pennsilvania, Philadelphia, Pennsylvania, USA.
  • Tchetche D; IRCCS Pol San Donato, Milan, Italy.
  • Bartorelli A; Kerckhoff Klinik, Bad Nauheim, Germany.
  • Kapadia S; Hospital Universitario Reina Sofia, Cordoba, Spain.
  • Stortecky S; Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Amat-Santos I; Clinique Pasteur, Toulouse, France.
  • Wijeysundera HC; Centro Cardiologico Monzino, IRCCS, University of Milan, Italy.
  • Lisko J; Cleveland Clinic, Cleveland, Ohio, USA.
  • Gutiérrez-Ibanes E; Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Switzerland.
  • Serra V; CIBERCV, Hospital Clinico Universitario de Valladolid, Valladolid, Spain.
  • Salido L; Sunnybrook Health Science Center, Toronto, Canada.
  • Alkhodair A; Emory University School of Medicine, Atlanta, Georgia, USA.
  • Livi U; Instituto de Investigación Universitaria Gregorio Marañón, Hospital Gregorio Marañón, Madrid, Spain.
  • Chakravarty T; Hospital Vall d'Hebron, Barcelona, Spain.
  • Lerakis S; Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Vilalta V; St Paul's Hospital, Vancouver, Canada.
  • Regueiro A; University Hospital of Udine, Udine, Italy.
  • Romaguera R; Cedars-Sinai Heart Institute, Los Angeles, California, USA.
  • Barbanti M; Emory University School of Medicine, Atlanta, Georgia, USA.
  • Masson JB; Mount Sinai Hospital, New York, New York, USA.
  • Maes F; Hospital Germans Trias i Pujol, Badalona, Spain.
  • Fiorina C; Hospital Clinic, Barcelona, Spain.
  • Miceli A; Hospital de Bellvitge, L'Hospitalet de Llobregat, Spain.
  • Kodali S; A.O.U. Policlinico Vittorio Emanuele, University of Catania, Catania, Italy.
  • Ribeiro HB; Centre Hospitalier de l'Universite de Montreal, Montreal, Canada.
  • Mangione JA; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • de Brito FS; ASST-Spedali Civili di Brescia, Brescia, Italy.
  • Actis Dato GM; Fondazione Toscana G. Monasterio, Massa, Italy.
  • Rosato F; Istituto Clinico Sant'Ambrogio, Milan, Italy.
  • Ferreira MC; Columbia University Medical Center, New York, New York, USA.
Clin Infect Dis ; 73(11): e3750-e3758, 2021 12 06.
Article em En | MEDLINE | ID: mdl-33733675
BACKGROUND: Procedural improvements combined with the contemporary clinical profile of patients undergoing transcatheter aortic valve replacement (TAVR) may have influenced the incidence and outcomes of infective endocarditis (IE) following TAVR. We aimed to determine the temporal trends, characteristics, and outcomes of IE post-TAVR. METHODS: Observational study including 552 patients presenting definite IE post-TAVR. Patients were divided in 2 groups according to the timing of TAVR (historical cohort [HC]: before 2014; contemporary cohort [CC]: after 2014). RESULTS: Overall incidence rates of IE were similar in both cohorts (CC vs HC: 5.45 vs 6.52 per 1000 person-years; P = .12), but the rate of early IE was lower in the CC (2.29‰ vs 4.89‰, P < .001). Enterococci were the most frequent microorganism. Most patients presented complicated IE ( CC: 67.7%; HC: 69.6%; P = .66), but the rate of surgical treatment remained low (CC: 20.7%; HC: 17.3%; P = .32). The CC exhibited lower rates of in-hospital acute kidney injury (35.1% vs 44.6%; P = .036) and in-hospital (26.6% vs 36.4%; P = .016) and 1-year (37.8% vs 53.5%; P < .001) mortality. Higher logistic EuroScore, Staphylococcus aureus etiology, and complications (stroke, heart failure, and acute renal failure) were associated with in-hospital mortality in multivariable analyses (P < .05 for all). CONCLUSIONS: Although overall IE incidence has remained stable, the incidence of early IE has declined in recent years. The microorganism, high rate of complications, and very low rate of surgical treatment remained similar. In-hospital and 1-year mortality rates were high but progressively decreased over time.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Endocardite / Endocardite Bacteriana / Substituição da Valva Aórtica Transcateter Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Endocardite / Endocardite Bacteriana / Substituição da Valva Aórtica Transcateter Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article